Keros Therapeutics Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Keros Therapeutics stock has a consensus rating of "Buy" and an average price target of $19.83. The average 1-year stock price forecast is 86.90% higher than the current stock price, while the lowest is $16 (+50.80%) and the highest is $25 (+135.63%).

Price Target: $19.83 (+86.90%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$16	$19.83	$19	$25
Change	+50.80%	+86.90%	+79.08%	+135.63%

Analyst Ratings

The average analyst rating for Keros Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Jan '26	Feb '26	Mar '26	May '26	Jun '26	Aug '26
Strong Buy	6	5	5	4	4	4
Buy	0	0	0	0	0	0
Hold	4	4	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	9	9	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Zemansky Bank of America Securities	Bank of America Securities	Hold Reiterates $20 → $17	Hold	Reiterates	$20 → $17	+60.23%	Aug 11, 2026
Yun Zhong Wedbush	Wedbush	Hold Maintains $16	Hold	Maintains	$16	+50.80%	Aug 4, 2026
Benjamin Burnett Wells Fargo	Wells Fargo	Buy Reiterates $20 → $18	Buy	Reiterates	$20 → $18	+69.65%	Aug 4, 2026
Andres Y. Maldonado H.C. Wainwright	H.C. Wainwright	Buy Reiterates $20	Buy	Reiterates	$20	+88.50%	Aug 4, 2026
Matt Phipps William Blair	William Blair	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Aug 4, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

16.37M

from 244.06M

-93.29%

from 244.06M

Revenue Next Year

4.71M

from 16.37M

-71.21%

from 16.37M

EPS This Year

-5.14

from 2.30

EPS Next Year

-6.61

from -5.14

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	20.10M	-	151.00K	3.55M	244.06M	16.37M
Revenue Growth	-	-	-	2,250.99%	6,774.96%	-93.29%
Operating Income	-56.37M	-114.79M	-169.94M	-210.83M	70.57M	-118.30M
Net Income	-58.74M	-104.68M	-152.99M	-187.35M	87.01M	-108.44M
EPS	-	-	-	-	2.30	-5.14
Free Cash Flow	-39.48M	-33.84M	-81.25M	-108.31M	66.24M	-83.13M
No. Analysts	-	-	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	22.0M
Avg	16.4M
Low	1.1M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-91.0%
Avg	-93.3%
Low	-99.6%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-4.62
Avg	-5.14
Low	-5.90

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-